Updated Aug. 30, 2013 at 7:32 a.m.

Premium Lock Value of pharma deals increase for early to mid-stage compounds, report says

Published: 2013-08-30 06:00:00
Updated: 2013-08-30 07:32:05

Biotech industry Biotech industry Image 1 of 2 · Next Image…

While early and mid-stage deal values are going up, there's little data to report on phase III compounds. Read more about Morrison & Foerster's conclusions from the firm's BioMeter report....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Scroll